Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | Case report

Methotrexate

Symptomatic leukoencephalopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lahoti A, et al. Methotrexate(MTX) Induced Leukoencephalopathy(LE) and Relation of Vitamin B12, Folate and / or Homocysteine Levels with MTX Toxicity: A Prospective Study. Blood 138 (Suppl. 1): 23 Nov 2021. Available from: URL: http://doi.org/10.1182/blood-2021-153241 [abstract] Lahoti A, et al. Methotrexate(MTX) Induced Leukoencephalopathy(LE) and Relation of Vitamin B12, Folate and / or Homocysteine Levels with MTX Toxicity: A Prospective Study. Blood 138 (Suppl. 1): 23 Nov 2021. Available from: URL: http://​doi.​org/​10.​1182/​blood-2021-153241 [abstract]
Metadaten
Titel
Methotrexate
Symptomatic leukoencephalopathy: case report
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12215-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Methotrexate

Case report

Antibacterials

Case report

Asparaginase